Danbury – October 27, 2026 -- CellsBin has received a Direct-to-Phase II Small Business Innovation Research (SBIR) award from the National Cancer Institute (NCI) to advance CB-Insight, its blood-based test for multiple myeloma, a cancer of plasma cells in the bone marrow.

ARLINGTON, Va. – October 27, 2026 -- March of Dimes has awarded $150,000 each to two early-career researchers, committing $300,000 in total through its 2026 Basil O'Connor Starter Scholar Research Awards. The recipients are Dr. Helen Vuong, PhD, of the University of Minnesota, Twin Cities, and Dr. Laurie Eldredge, MD, PhD, of the University of Washington School of Medicine.

SALT LAKE CITY – October 27, 2026 -- Thorne converted 80% of its paper batch records to electronic batch records (EBR) in 2026 using MasterControl Manufacturing Excellence (Mx), earning the Manufacturing Excellence Award at MasterControl's 2026 Masters Summit. The October event named four winners of the Masters of Excellence Awards, which recognize MasterControl customers in quality management, manufacturing, asset excellence and innovation.

PROVIDENCE – October 27, 2026 -- The Rhode Island Life Science Hub (RILSH) and the Massachusetts Life Sciences Center (MLSC) signed a Memorandum of Understanding to plan how Rhode Island hospitals can join the MLSC-supported biobank network, with Alzheimer's and other brain diseases as the first focus.

Irvine – October 27, 2026 -- SBC Medical Group Holdings (Nasdaq: SBC) has begun in-house development of a DNA methylation test to estimate biological age, entering a longevity market that Report Ocean projects will grow from about $800 billion in 2025 to about $2 trillion by 2035.

United States – October 27, 2026 -- Healthcare faces a projected shortage of up to 3.2 million workers by 2026, and IntelePeer argues that gap is making per-seat enterprise software economically obsolete as buyers shift from purchasing tools to purchasing completed work.

GLOBAL – October 27, 2026 -- Only about 6% of organizations have scaled AI to meaningful financial impact, leaving 94% stuck between experimentation and abandonment, according to McKinsey's 2024 State of AI survey cited by IntelePeer in a new healthcare analysis.

The vendor calls the gap "Pilot Purgatory": an AI voice agent handles a scheduling demo flawlessly, a pilot is approved, and within six months it is shelved. IntelePeer argues the fix is architecture rather than a better algorithm.

TAMPA – October 27, 2026 -- Akari Therapeutics (Nasdaq: AKTX) is targeting a First-In-Human trial of its lead antibody drug conjugate (ADC), AKTX-101, by mid-2027, after starting IND-enabling studies. The company laid out its investment case in the Virtual Investor "Why Now" on-demand conference.

CEO Abizer Gaslightwala argued that now is a pivotal time for Akari. He cited a fast-changing ADC landscape and rising industry demand for differentiated payload technologies.

United States – October 27, 2026 -- An analysis of 5,723 patients on Foundayo (oral orforglipron) found that 40.3% had no evidence of prior GLP-1 medication use, according to Truveta, which is pitching real-time "healthcare intelligence" to life science, healthcare and government teams.

Foundayo uptake runs mostly through primary care

Truveta researchers used Truveta Data to identify patients with a Foundayo prescription or medication dispense between April 1 and July 6, 2026. The drug was approved for obesity in April 2026.

United States – October 27, 2026 -- Robotic assistance in total knee arthroplasty (TKA) rose from 12.4% of procedures in 2018 to 36.1% in 2026, a 191% relative increase, according to an analysis of 362,667 procedures in Truveta Data.

Robotic assistance was used in 24.3% of all procedures in the study period, which ran from January 2018 to August 2026. Robotic-assisted cases ran longer. Median operation time was 136 minutes (IQR 116-160), against 126 minutes (IQR 109-149) without robotics.